| The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ... Annals of oncology 26 (2), 259-271, 2015 | 2647 | 2015 |
| Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ... Breast Cancer Research 10, 1-11, 2008 | 1045 | 2008 |
| CD4+ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013 | 1012 | 2013 |
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ... The lancet oncology 15 (4), 406-414, 2014 | 922 | 2014 |
| Subclonal diversification of primary breast cancer revealed by multiregion sequencing LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ... Nature medicine 21 (7), 751-759, 2015 | 834 | 2015 |
| Liquid biopsy enters the clinic—implementation issues and future challenges M Ignatiadis, GW Sledge, SS Jeffrey Nature reviews Clinical oncology 18 (5), 297-312, 2021 | 751 | 2021 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 672 | 2017 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017 | 604 | 2017 |
| Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling HA Azim Jr, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ... Clinical cancer research 18 (5), 1341-1351, 2012 | 418 | 2012 |
| Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer KS Saini, S Loi, E de Azambuja, O Metzger-Filho, ML Saini, M Ignatiadis, ... Cancer treatment reviews 39 (8), 935-946, 2013 | 407 | 2013 |
| Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility M Ignatiadis, M Lee, SS Jeffrey Clinical Cancer Research 21 (21), 4786-4800, 2015 | 392 | 2015 |
| Luminal breast cancer: from biology to treatment M Ignatiadis, C Sotiriou Nature reviews Clinical oncology 10 (9), 494-506, 2013 | 314 | 2013 |
| Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis Y Bareche, D Venet, M Ignatiadis, P Aftimos, M Piccart, F Rothe, ... Annals of oncology 29 (4), 895-902, 2018 | 306 | 2018 |
| Different prognostic value of cytokeratin-19 mRNA–positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer M Ignatiadis, N Xenidis, M Perraki, S Apostolaki, E Politaki, M Kafousi, ... Journal of clinical oncology 25 (33), 5194-5202, 2007 | 304 | 2007 |
| Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer N Xenidis, M Ignatiadis, S Apostolaki, M Perraki, K Kalbakis, S Agelaki, ... J Clin Oncol 27 (13), 2177-2184, 2009 | 300 | 2009 |
| Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors DJ McBride, AK Orpana, C Sotiriou, H Joensuu, PJ Stephens, LJ Mudie, ... Genes, Chromosomes and Cancer 49 (11), 1062-1069, 2010 | 297 | 2010 |
| Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early … M Ignatiadis, G Kallergi, M Ntoulia, M Perraki, S Apostolaki, M Kafousi, ... Clinical Cancer Research 14 (9), 2593-2600, 2008 | 293 | 2008 |
| Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials FC Bidard, T Fehm, M Ignatiadis, JB Smerage, C Alix-Panabières, ... Cancer and Metastasis Reviews 32 (1), 179-188, 2013 | 278 | 2013 |
| Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ... PloS one 6 (6), e20980, 2011 | 277 | 2011 |
| Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer F Rothé, JF Laes, D Lambrechts, D Smeets, D Vincent, M Maetens, ... Annals of oncology 25 (10), 1959-1965, 2014 | 272 | 2014 |
Christos SotiriouUniversité Libre de BruxellesEmail verificata su bordet.be
